Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
The medical treatment of peptic ulcer disease
Autore:
Louw, JA; Marks, IN;
Indirizzi:
New Groote Schuur Hosp, Gastrointestinal Clin E23, ZA-7925 Observatory, South Africa New Groote Schuur Hosp Observatory South Africa ZA-7925 ry, South Africa
Titolo Testata:
CURRENT OPINION IN GASTROENTEROLOGY
fascicolo: 6, volume: 17, anno: 2001,
pagine: 497 - 502
SICI:
0267-1379(200111)17:6<497:TMTOPU>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
RANDOMIZED CONTROLLED TRIAL; PYLORI ERADICATION TREATMENT; PROTON-PUMP INHIBITORS; LOW-DOSE ASPIRIN; HELICOBACTER-PYLORI; GASTROINTESTINAL TOXICITY; RHEUMATOID-ARTHRITIS; HEALTHY-SUBJECTS; TRIPLE THERAPY; OMEPRAZOLE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
39
Recensione:
Indirizzi per estratti:
Indirizzo: Louw, JA New Groote Schuur Hosp, Gastrointestinal Clin E23, ZA-7925 Observatory, South Africa New Groote Schuur Hosp Observatory South Africa ZA-7925 Africa
Citazione:
J.A. Louw e I.N. Marks, "The medical treatment of peptic ulcer disease", CURR OPIN G, 17(6), 2001, pp. 497-502

Abstract

There is continued interest in the role of H. pylori in both uninvestigated and non ulcer dyspepsia. The literature on this issue provided interesting, if at times conflicting findings, leaving the clinician with little choice but to use clinical judgment when dealing with these patients. On the Therapeutic front, a "new" proton pump inhibitor, with impressive early efficacy data has been launched, while an IV proton pump inhibitor formulation has reached a number of markets. Emerging data on the use of potent acid suppression in especially GI bleeding will almost certainly impact on the use of these agents. The gastrointestinal effects of low dose aspirin use have received attention, while the COX1-sparing agents have now started to impact on clinical practice. Two large clinical outcomes studies with these agents have been published. Both indicate at least some benefit, but raise interesting questions with regard to the use of these agents in the clinical setting. Curr Opin Gastroenterol 2001, 17:497-502 (C) 2001 Lippincott Williams & Wilkins, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/04/20 alle ore 12:17:27